News
THL buying clinical research organization Celerion for $1.8B
THL Partners is acquiring a majority stake in pharma services company Celerion from H.I.G. for $1.8 billion, Axios Pro has learned. Why it matters: Private equityinterest in pharma services persists,as biotech funding rebounds and more complex drugs come to market. Inside the room: After a Lazard and Bank of America-run process, Celerion traded for around 12x its $150 million of EBITDA,
